Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise... - 2Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- 3Consumer outlook on UK economy falls to two-year low
- 4Posts falsely claim Netanyahu video fabricated to cover up his death
- 5Uzbekistan launches €9.46 billion green energy push, covering nation’s power needs
- Lift Your Style: Famous Hairdos for Ladies
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- Exhaustive Experiences into Prudent Senior Living in the UK
- Here are 10 stores where you can get a free Thanksgiving turkey
- A definitive Manual for Choosing Indoor Plants Ideal for Your Space
- A Manual for Pick High Evaluated Food Conveyance Administrations In Significant Urban communities For 2024
- The Fate of Rest: Patterns in Shrewd Beds
- Joshua Made Last-Second Seat Change That Saved His Life
- New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026
